argenx SE has a consensus price target of $520.35 based on the ratings of 25 analysts. The high is $641 issued by TD Cowen on December 12, 2023. The low is $408 issued by Scotiabank on March 26, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, Truist Securities, and Wedbush on July 23, 2024, July 22, 2024, and July 22, 2024, respectively. With an average price target of $535 between Oppenheimer, Truist Securities, and Wedbush, there's an implied 15.21% upside for argenx SE from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/23/2024 | Buy Now | 17.58% | Oppenheimer | Leland Gershell | → $546 | Upgrade | Perform → Outperform | Get Alert |
07/22/2024 | Buy Now | 16.29% | Truist Securities | Joon Lee | $480 → $540 | Maintains | Buy | Get Alert |
07/22/2024 | Buy Now | 11.77% | Wedbush | David Nierengarten | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
07/17/2024 | Buy Now | 8.54% | HC Wainwright & Co. | Douglas Tsao | $490 → $504 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 11.77% | Wedbush | David Nierengarten | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
07/12/2024 | Buy Now | 14.78% | Evercore ISI Group | Gavin Clark-Gartner | $478 → $533 | Maintains | Outperform | Get Alert |
07/01/2024 | Buy Now | 11.77% | Wedbush | David Nierengarten | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
06/26/2024 | Buy Now | 11.77% | Wedbush | David Nierengarten | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert |
06/26/2024 | Buy Now | 5.52% | HC Wainwright & Co. | Douglas Tsao | $448 → $490 | Maintains | Buy | Get Alert |
06/25/2024 | Buy Now | 3.37% | Truist Securities | Joon Lee | $440 → $480 | Maintains | Buy | Get Alert |
06/24/2024 | Buy Now | 30.72% | B of A Securities | Tazeen Ahmad | $535 → $607 | Reiterates | Buy → Buy | Get Alert |
06/24/2024 | Buy Now | 7.68% | Stifel | Alex Thompson | $485 → $500 | Maintains | Buy | Get Alert |
06/24/2024 | Buy Now | 15.21% | Piper Sandler | Allison Bratzel | $522 → $535 | Maintains | Overweight | Get Alert |
06/24/2024 | Buy Now | 16.72% | Wells Fargo | Derek Archila | $478 → $542 | Maintains | Overweight | Get Alert |
06/24/2024 | Buy Now | -3.52% | HC Wainwright & Co. | Douglas Tsao | $448 → $448 | Reiterates | Buy → Buy | Get Alert |
06/17/2024 | Buy Now | 12.41% | Piper Sandler | Allison Bratzel | $522 → $522 | Maintains | Overweight | Get Alert |
06/14/2024 | Buy Now | -3.52% | HC Wainwright & Co. | Douglas Tsao | $448 → $448 | Reiterates | Buy → Buy | Get Alert |
05/28/2024 | Buy Now | 9.83% | Morgan Stanley | Matthew Harrison | $515 → $510 | Maintains | Overweight | Get Alert |
05/13/2024 | Buy Now | 7.68% | JP Morgan | James Gordon | $560 → $500 | Maintains | Overweight | Get Alert |
05/10/2024 | Buy Now | -3.52% | HC Wainwright & Co. | Douglas Tsao | $451 → $448 | Maintains | Buy | Get Alert |
05/10/2024 | Buy Now | 0.78% | JMP Securities | Jason Butler | $471 → $468 | Maintains | Market Outperform | Get Alert |
04/18/2024 | Buy Now | 12.2% | Wedbush | David Nierengarten | → $521 | Reiterates | Outperform → Outperform | Get Alert |
04/18/2024 | Buy Now | -2.88% | HC Wainwright & Co. | Douglas Tsao | → $451 | Reiterates | Buy → Buy | Get Alert |
03/27/2024 | Buy Now | -2.88% | HC Wainwright & Co. | Douglas Tsao | $451 → $451 | Maintains | Buy | Get Alert |
03/26/2024 | Buy Now | -12.14% | Scotiabank | George Farmer | $402 → $408 | Maintains | Sector Perform | Get Alert |
03/22/2024 | Buy Now | 1.43% | JMP Securities | Jason Butler | → $471 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/05/2024 | Buy Now | -5.25% | Truist Securities | Joon Lee | $370 → $440 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | -13.43% | Scotiabank | George Farmer | $346 → $402 | Maintains | Sector Perform | Get Alert |
03/01/2024 | Buy Now | 1.43% | JMP Securities | Jason Butler | $462 → $471 | Maintains | Market Outperform | Get Alert |
03/01/2024 | Buy Now | 5.52% | Baird | Joel Beatty | $505 → $490 | Maintains | Outperform | Get Alert |
03/01/2024 | Buy Now | -2.88% | HC Wainwright & Co. | Douglas Tsao | → $451 | Reiterates | Buy → Buy | Get Alert |
02/20/2024 | Buy Now | 2.94% | Wells Fargo | Derek Archila | $472 → $478 | Maintains | Overweight | Get Alert |
02/15/2024 | Buy Now | — | Wolfe Research | Andy Chen | — | Initiates | → Peer Perform | Get Alert |
01/26/2024 | Buy Now | 12.41% | Piper Sandler | Allison Bratzel | $518 → $522 | Maintains | Overweight | Get Alert |
01/18/2024 | Buy Now | 11.55% | Piper Sandler | Allison Bratzel | $515 → $518 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | -6.11% | Evercore ISI Group | Gavin Clark-Gartner | $594 → $436 | Maintains | Outperform | Get Alert |
12/21/2023 | Buy Now | -25.49% | Scotiabank | George Farmer | $444 → $346 | Maintains | Sector Perform | Get Alert |
12/21/2023 | Buy Now | -20.32% | Truist Securities | Joon Lee | $550 → $370 | Maintains | Buy | Get Alert |
12/21/2023 | Buy Now | 10.91% | Piper Sandler | Allison Bratzel | $575 → $515 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | 1.21% | Wells Fargo | Derek Archila | $585 → $470 | Maintains | Overweight | Get Alert |
12/21/2023 | Buy Now | -2.88% | HC Wainwright & Co. | Douglas Tsao | $582 → $451 | Maintains | Buy | Get Alert |
12/21/2023 | Buy Now | 11.98% | Raymond James | Danielle Brill | $580 → $520 | Maintains | Strong Buy | Get Alert |
12/20/2023 | Buy Now | 18.44% | Truist Securities | Joon Lee | → $550 | Reiterates | Buy → Buy | Get Alert |
12/18/2023 | Buy Now | 20.6% | Stifel | Alex Thompson | $557 → $560 | Maintains | Buy | Get Alert |
12/12/2023 | Buy Now | 38.04% | TD Cowen | Yaron Werber | $612 → $641 | Maintains | Outperform | Get Alert |
12/05/2023 | Buy Now | 20.6% | JP Morgan | James Gordon | $615 → $560 | Maintains | Overweight | Get Alert |
11/30/2023 | Buy Now | 26.2% | Morgan Stanley | Matthew Harrison | $607 → $586 | Maintains | Overweight | Get Alert |
11/29/2023 | Buy Now | 18.44% | Truist Securities | Joon Lee | $570 → $550 | Maintains | Buy | Get Alert |
11/29/2023 | Buy Now | 27.27% | Citigroup | Samantha Semenkow | $610 → $591 | Maintains | Buy | Get Alert |
11/29/2023 | Buy Now | 25.33% | HC Wainwright & Co. | Douglas Tsao | $595 → $582 | Maintains | Buy | Get Alert |
11/29/2023 | Buy Now | 24.9% | Raymond James | Danielle Brill | $600 → $580 | Maintains | Strong Buy | Get Alert |
11/01/2023 | Buy Now | 22.75% | Truist Securities | Joon Lee | → $570 | Reiterates | Buy → Buy | Get Alert |
11/01/2023 | Buy Now | 30.72% | Morgan Stanley | Matthew Harrison | $604 → $607 | Maintains | Overweight | Get Alert |
10/02/2023 | Buy Now | 22.75% | Truist Securities | Joon Lee | → $570 | Reiterates | Buy → Buy | Get Alert |
09/18/2023 | Buy Now | 28.13% | HC Wainwright & Co. | Douglas Tsao | → $595 | Reiterates | Buy → Buy | Get Alert |
08/31/2023 | Buy Now | 29.21% | Piper Sandler | Allison Bratzel | $595 → $600 | Maintains | Overweight | Get Alert |
07/31/2023 | Buy Now | 11.12% | Scotiabank | George Farmer | → $516 | Initiates | → Sector Perform | Get Alert |
07/28/2023 | Buy Now | 27.06% | Guggenheim | Yatin Suneja | $545 → $590 | Maintains | Buy | Get Alert |
07/28/2023 | Buy Now | 31.15% | Wells Fargo | Derek Archila | $606 → $609 | Maintains | Overweight | Get Alert |
07/28/2023 | Buy Now | 28.13% | HC Wainwright & Co. | Douglas Tsao | → $595 | Reiterates | Buy → Buy | Get Alert |
07/24/2023 | Buy Now | 23.83% | Piper Sandler | Allison Bratzel | $545 → $575 | Maintains | Overweight | Get Alert |
07/24/2023 | Buy Now | 22.75% | UBS | Xian Deng | $480 → $570 | Downgrade | Buy → Neutral | Get Alert |
07/21/2023 | Buy Now | 28.13% | HC Wainwright & Co. | Douglas Tsao | $494 → $595 | Maintains | Buy | Get Alert |
07/20/2023 | Buy Now | 29.64% | Morgan Stanley | Matthew Harrison | $452 → $602 | Maintains | Overweight | Get Alert |
07/18/2023 | Buy Now | 27.49% | Citigroup | Samantha Semenkow | $450 → $592 | Maintains | Buy | Get Alert |
07/18/2023 | Buy Now | 17.37% | Guggenheim | Yatin Suneja | $505 → $545 | Maintains | Buy | Get Alert |
07/18/2023 | Buy Now | 22.75% | Wedbush | David Nierengarten | → $570 | Reiterates | Outperform → Outperform | Get Alert |
07/18/2023 | Buy Now | 29.21% | Raymond James | Danielle Brill | $460 → $600 | Maintains | Strong Buy | Get Alert |
07/18/2023 | Buy Now | 6.38% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
07/17/2023 | Buy Now | — | HC Wainwright & Co. | Douglas Tsao | — | Reiterates | Buy → Buy | Get Alert |
07/17/2023 | Buy Now | 10.47% | Jefferies | Akash Tewari | $497 → $513 | Maintains | Buy | Get Alert |
07/17/2023 | Buy Now | -6.11% | Evercore ISI Group | Gavin Clark-Gartner | → $436 | Reinstates | → Outperform | Get Alert |
06/22/2023 | Buy Now | 6.38% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | -2.23% | Wedbush | David Nierengarten | → $454 | Reiterates | Outperform → Outperform | Get Alert |
06/21/2023 | Buy Now | 6.38% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 6.38% | HC Wainwright & Co. | Douglas Tsao | → $494 | Reiterates | Buy → Buy | Get Alert |
05/31/2023 | Buy Now | 3.37% | UBS | Xian Deng | → $480 | Initiates | → Buy | Get Alert |
05/05/2023 | Buy Now | -2.66% | Morgan Stanley | Matthew Harrison | $450 → $452 | Maintains | Overweight | Get Alert |
05/05/2023 | Buy Now | -5.25% | Truist Securities | Joon Lee | $420 → $440 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | -4.17% | JMP Securities | Jason Butler | $448 → $445 | Maintains | Market Outperform | Get Alert |
05/05/2023 | Buy Now | 6.38% | HC Wainwright & Co. | Douglas Tsao | $482 → $494 | Maintains | Buy | Get Alert |
05/05/2023 | Buy Now | -0.94% | Raymond James | Danielle Brill | $455 → $460 | Maintains | Strong Buy | Get Alert |
05/03/2023 | Buy Now | 3.8% | HC Wainwright & Co. | Douglas Tsao | → $482 | Reiterates | → Buy | Get Alert |
04/25/2023 | Buy Now | -3.09% | Citigroup | Samantha Semenkow | → $450 | Initiates | → Buy | Get Alert |
04/21/2023 | Buy Now | -6.97% | Wedbush | David Nierengarten | → $432 | Reiterates | → Outperform | Get Alert |
03/20/2023 | Buy Now | 3.8% | HC Wainwright & Co. | Douglas Tsao | $480 → $482 | Maintains | Buy | Get Alert |
03/03/2023 | Buy Now | -6.32% | SVB Leerink | Thomas Smith | $430 → $435 | Maintains | Outperform | Get Alert |
03/03/2023 | Buy Now | -3.52% | JMP Securities | Roy Buchanan | $443 → $448 | Maintains | Market Outperform | Get Alert |
03/03/2023 | Buy Now | 3.37% | HC Wainwright & Co. | Douglas Tsao | → $480 | Reiterates | → Buy | Get Alert |
02/23/2023 | Buy Now | 2.29% | Piper Sandler | Allison Bratzel | $465 → $475 | Maintains | Overweight | Get Alert |
01/25/2023 | Buy Now | -1.37% | Cowen & Co. | Yaron Werber | $441 → $458 | Maintains | Outperform | Get Alert |
01/10/2023 | Buy Now | 3.37% | HC Wainwright & Co. | Douglas Tsao | $440 → $480 | Maintains | Buy | Get Alert |
12/22/2022 | Buy Now | 2.94% | Stifel | Alex Thompson | $471 → $478 | Maintains | Buy | Get Alert |
12/07/2022 | Buy Now | — | William Blair | Myles Minter | — | Initiates | → Outperform | Get Alert |
10/28/2022 | Buy Now | -3.09% | Morgan Stanley | Matthew Harrison | $401 → $450 | Maintains | Overweight | Get Alert |
10/28/2022 | Buy Now | -9.55% | Truist Securities | Joon Lee | $410 → $420 | Maintains | Buy | Get Alert |
10/28/2022 | Buy Now | -5.25% | HC Wainwright & Co. | Douglas Tsao | $425 → $440 | Maintains | Buy | Get Alert |
10/28/2022 | Buy Now | -7.4% | SVB Leerink | Thomas Smith | $428 → $430 | Maintains | Outperform | Get Alert |
10/18/2022 | Buy Now | 1% | Wells Fargo | Derek Archila | $461 → $469 | Maintains | Overweight | Get Alert |
10/12/2022 | Buy Now | — | Oppenheimer | Leland Gershell | — | Initiates | → Perform | Get Alert |
The latest price target for argenx (NASDAQ:ARGX) was reported by Oppenheimer on July 23, 2024. The analyst firm set a price target for $546.00 expecting ARGX to rise to within 12 months (a possible 17.58% upside). 60 analyst firms have reported ratings in the last year.
The latest analyst rating for argenx (NASDAQ:ARGX) was provided by Oppenheimer, and argenx upgraded their outperform rating.
The last upgrade for argenx SE happened on July 23, 2024 when Oppenheimer raised their price target to $546. Oppenheimer previously had a perform for argenx SE.
The last downgrade for argenx SE happened on July 24, 2023 when UBS changed their price target from $480 to $570 for argenx SE.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of argenx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for argenx was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
While ratings are subjective and will change, the latest argenx (ARGX) rating was a upgraded with a price target of $0.00 to $546.00. The current price argenx (ARGX) is trading at is $464.36, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.